Impact of Supplemented Nutrition on Semen Quality, Epigenetic-Related Gene Expression, and Oxidative Status in Boars.

Animals (Basel)

Department of Reproduction, Fertility and Artificial Insemination, Faculty of Veterinary Medicine, University of Belgrade, 11000 Belgrade, Serbia.

Published: November 2024

This study investigates the impact of nutritional supplementation on semen quality, epigenetic-related gene expression, and oxidative status in boars. Thirty boars were divided into a control group and a treatment group receiving Espermaplus (a supplement containing various vitamins, amino acids, omega-3 fatty acids, and trace elements with antioxidant properties). The experiment was performed for 12 weeks. Semen samples were collected at four moments: before starting the supplementation and after 3 weeks, 8 weeks, and 12 weeks. Spermatozoa concentration, motility, and kinematics were assessed using the CASA system. The measured parameters included curvilinear velocity-VCL; straight-line velocity-VSL; average path velocity-VAP; curvilinear distance-DCL; straight line distance-DSL; distance of average path-DAP; amplitude of lateral head displacement-ALH; beat-cross frequency-BCF; and head activity-HAC. Moreover, superoxide dismutase (SOD) and glutathione peroxidase (GPx) activity in seminal plasma, as well as the concentration of thiobarbituric acid reactive substances (TBARS), were measured to assess oxidative stress levels in boar's seminal plasma. The expression of epigenetic-related genes such as Protamine 1 (), Protamine 2 (), and DNA-methyltransferase 3 alpha () were evaluated using real-time PCR. The treated group showed a significant increase in spermatozoa concentration ( = 0.003), total motility ( = 0.001), and progressive motility ( = 0.002) after 12 weeks compared to the control group. Kinematic parameters such as VCL, VSL, and VAP were also significantly higher ( < 0.001; = 0.028; < 0.001, respectively) in the treated group by the end of the experiment. SOD and GPx activities were consistently higher ( < 0.01; < 0.001, respectively) in the treated group, indicating enhanced antioxidative capacity. TBARS levels as an indicator of lipid peroxidation and oxidative damage were significantly lower ( < 0.01) in the treated group by the end of the study. Significant changes were observed in the expression of epigenetic-related genes. The supplementation of boar diets with Espermaplus significantly improved semen quality, reduced oxidative stress, and had an impact on the expression levels of certain epigenetic-related genes, suggesting that dietary antioxidants and bioactive compounds can enhance boar semen.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11591274PMC
http://dx.doi.org/10.3390/ani14223297DOI Listing

Publication Analysis

Top Keywords

treated group
16
semen quality
12
epigenetic-related genes
12
quality epigenetic-related
8
epigenetic-related gene
8
gene expression
8
expression oxidative
8
oxidative status
8
status boars
8
control group
8

Similar Publications

Importance: The open-label randomized phase 2 LACOG0415 trial evaluated 3 treatment strategies for patients with advanced castration-sensitive prostate cancer (CSPC): androgen deprivation therapy (ADT) plus abiraterone acetate and prednisone (AAP), apalutamide (APA) alone, or APA plus AAP.

Objective: To investigate the association of ADT plus AAP, APA alone, or APA plus AAP with health-related quality of life (HRQOL) in patients with advanced CSPC in the LACOG0415 trial.

Design, Setting, And Participants: The LACOG0415 randomized clinical trial comprised 128 patients with advanced CSPC who were randomized (1:1:1) to 1 of 3 treatment arms from October 16, 2017, to April 23, 2019.

View Article and Find Full Text PDF

Importance: The optimal configuration of a smoking cessation intervention in a lung cancer screening (LCS) setting has not yet been established.

Objective: To evaluate the efficacy of 3 tobacco treatment strategies of increasing integration and intensity in the LCS setting.

Design, Setting, And Participants: In this randomized clinical trial, LCS-eligible current smokers were randomized into 3 treatments: quitline (QL), QL plus (QL+), or integrated care (IC).

View Article and Find Full Text PDF

The effect of the aqueous extract of (AAI) on gentamicin (GEN)-induced kidney injury was investigated. The study involves 20 adult male Wistar rats (housed in four separate plastic cages) such that graded dosages of AAI were administered to the experimental group for 14 days per oral (PO) before exposure to GEN toxicity (100 mg/kg) for 1 week. At the end of the study, comparisons of some markers of renal functions, antioxidant status, and inflammatory and apoptotic markers were made between the control, GEN, and AAI-pretreated groups at < .

View Article and Find Full Text PDF

Fluid Distribution: Response to Intermittent Pneumatic Compression in People With and Without Primary Lymphedema.

Lymphat Res Biol

January 2025

Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, Australia.

Current understanding of changes in fluid distribution in response to the application of compression in primary lymphedema (PLE) is limited. This study measured fluid distribution before and after one application of standardized intermittent pneumatic compression (IPC) in the lower limbs of people with PLE, compared with those without lymphedema. High-frequency ultrasound (HFU) was used to measure dermal fluid, bioimpedance to measure segmental fluid, and percent water content (PWC) to measure fluid at specific anatomical points.

View Article and Find Full Text PDF

Background And Objectives: Safety and efficacy of IV onasemnogene abeparvovec has been demonstrated for patients with spinal muscular atrophy (SMA) weighing <8.5 kg. SMART was the first clinical trial to evaluate onasemnogene abeparvovec for participants weighing 8.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!